combination therapy with glp-1 receptor agonist and sglt2 inhibitor Blood pressure effects of inhibitors GLP‐1 agonists: Mechanisms, trial evidence and Real‐world data - Belančić - British Journal of Clinical Pharmacology GLP-1 Receptor Agonist Therapy With

Eur J Cell Biol (2017) 96:24053

Nausea and vomiting are less frequent in patients receiving EX-LAR than in patients taking EX (114)

With the right plan, you can take control of your health and reach your goals

Exenatide (Byetta and Bydureon, AstraZeneca), is a synthetic 39-amino acid peptide (first discovered as exendin-4 in the saliva of the gila monster, Heloderma suspectum) (Figure 8) [879]

Head-to-head phentermine versus GLP-1 trials are limited

Although the use of GLP-1 RAs prior to EGD or colonoscopy has resulted in poor outcomes in terms of poor visibility/preparation scores and the need for aborted/repeated procedures, their use prior to concurrent EGD and colonoscopy might not have the same detrimental effect